Diaceutics PLC (FRA:7DC)
Germany flag Germany · Delayed Price · Currency is EUR
1.790
+0.080 (4.68%)
At close: Jan 30, 2026

Diaceutics Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-1.52-1.7-1.750.720.560.26
Depreciation & Amortization
3.583.163.271.661.020.7
Other Amortization
1.481.471.51.350.780.11
Loss (Gain) From Sale of Assets
--0---
Asset Writedown & Restructuring Costs
0.090.09----
Stock-Based Compensation
1.041.020.450.540.370.29
Other Operating Activities
-1.13-2.08-0.621.16-0.51-1.6
Change in Accounts Receivable
-2.43-4.68-2.16-1.59-1.50.55
Change in Accounts Payable
-0.993.370.621.27-0.16-0.06
Operating Cash Flow
0.10.651.315.10.570.25
Operating Cash Flow Growth
-94.11%-50.34%-74.27%794.03%125.30%-
Capital Expenditures
-0.09-0.1-0.13-0.19-0.57-0.14
Sale (Purchase) of Intangibles
-5.91-4.53-4.73-4.68-5.04-6.16
Other Investing Activities
0.450.60.650.11--
Investing Cash Flow
-5.56-4.03-4.21-4.76-5.6-6.29
Long-Term Debt Repaid
--0.2-0.18-0.16-0.05-
Net Debt Issued (Repaid)
-0.24-0.2-0.18-0.16-0.05-
Issuance of Common Stock
00.14-0.13-19.61
Repurchase of Common Stock
---0.05-0.1-0.17-
Other Financing Activities
-0-0-0.01-0.06-0.06-
Financing Cash Flow
-0.24-0.06-0.24-0.19-0.2719.61
Foreign Exchange Rate Adjustments
-0.67-0.48-0.040.02-0.28-0.04
Net Cash Flow
-6.37-3.92-3.170.17-5.5813.54
Free Cash Flow
0.010.551.194.910.010.12
Free Cash Flow Growth
-99.39%-53.54%-75.84%98100.00%-95.69%-
Free Cash Flow Margin
0.03%1.71%5.00%25.17%0.04%0.91%
Free Cash Flow Per Share
-0.010.010.06-0.00
Cash Interest Paid
000.010.060.06-
Cash Income Tax Paid
0.61.33-0.69-1.390.330.43
Levered Free Cash Flow
-4.1-2.35-1.18-0.35-5.55-6.39
Unlevered Free Cash Flow
-4.07-2.31-1.14-0.28-5.49-6.36
Change in Working Capital
-3.42-1.3-1.54-0.33-1.660.49
Source: S&P Global Market Intelligence. Standard template. Financial Sources.